Danli Xin

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 1

Top Topics

Dna Damage Response

Diabetic Retinopathy

Epidermal Growth Factor Receptor

Pseudomonas Aeruginosa

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Hongyan Yao, Danli Xin, Zongyi Zhan, Zi-Jing Li
Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)